Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

A Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies.

D Ball Edward, MD, Bruno C. Medeiros, MD, Larissa Balaian, PhD, Tracy Roque, Sue Corringham, RN, Richa Rajwanshi, Steve Coutre, MD, Jason R Gotlib, MD, MS, Asad Bashey, MD, PhD, Karen Messer, PhD

Blood (2009) 114 (22): 2049.

https://doi.org/10.1182/blood.V114.22.2049.2049

Published: 2009

Journal Articles

Prognostic Factors for Long-Term Survival in Metastatic Breast Cancer Patients Treated with High Dose Chemotherapy and Autologous Stem Cell Transplantation

Annette Von Drygalski, MD, Thuy B Tran, BA, Karen Messer, PhD, Minya Pu, MS, Sue Corringham, RN, Connie Nelson, BS, Edward D Ball, MD

Blood (2008) 112 (11): 4460.

https://doi.org/10.1182/blood.V112.11.4460.4460

Published: 2008

Journal Articles

Independent and Interdependent Influence of Number of CD34+ Cells and Use of G-CSF on Outcomes in Autologous PBSCT Patients

Meghana Trivedi, PharmD, PhD, Sue Corringham, RN, Sam Martinez, PharmD, Katherine Medley, PharmD, Edward D Ball, MD

Blood (2008) 112 (11): 4319.

https://doi.org/10.1182/blood.V112.11.4319.4319

Published: 2008

Journal Articles

Clinical Trial of Therapeutic Blockade of CTLA4 with Ipilimumab in Patients with Relapse of Malignancy Following Allogeneic Hematopoietic Transplantation.

Asad Bashey, MD, PhD, Bridget Medina, Sue Corringham, RN, Mildred Pasek, Ewa Carrier, MD, Linda Vrooman, RN, Howard Streicher, MD, Israel Lowy, MD, Scott R. Solomon, MD, Lawrence E. Morris, MD, Kent Holland, MD, James R. Mason, MD, Robert J. Soiffer, MD, Edward D. Ball, MD

Blood (2007) 110 (11): 1646.

https://doi.org/10.1182/blood.V110.11.1646.1646

Published: 2007

Journal Articles

Phase I Study of Ipilimumab (Neutralizing Monoclonal Anti-CTLA4 Antibody) To Treat Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation: Evidence of Tumor Regression without Induction of GVHD.

Asad Bashey, MD, PhD, Bridget Medina, Sue Corringham, RN, Mildred Pasek, RN, Ewa Carrier, MD, Howard Streicher, MD, Israel Lowy, MD, James R. Mason, MD, Robert J. Soiffer, MD, Edward D. Ball, MD

Blood (2006) 108 (11): 410.

https://doi.org/10.1182/blood.V108.11.410.410

Published: 2006

Journal Articles

BEAM Versus CEB Conditioning for Autologous Transplantation in Patients with Non-Hodgkin’s Lymphoma and Hodgkin’s Disease: A Single Center Comparative Study of 219 Patients.

Asad Bashey, MD, PhD, Oralia Loza, Bridget Medina, Katherine Keesee, PharmD, Sue Corringham, RN, Januario Castro, MD, Peter Holman, MD, Thomas A. Lane, MD, Edward D. Ball, MD, Ewa Carrier, MD

Blood (2005) 106 (11): 2079.

https://doi.org/10.1182/blood.V106.11.2079.2079

Published: 2005

Journal Articles

Phase I Study of a Neutralizing Monoclonal Anti-CTLA4 Antibody (MDX-010) in Patients with Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation.

Asad Bashey, MD, PhD, Bridget Medina, Sue Corringham, RN, Mildred Pasek, Ewa Carrier, MD, Howard Streicher, MD, Israel Lowy, MD, PhD, James Mason, MD, Robert J. Soiffer, MD, Edward D. Ball, MD

Blood (2005) 106 (11): 2017.

https://doi.org/10.1182/blood.V106.11.2017.2017

Published: 2005

Journal Articles

Intermediate Dose Cyclophosphamide Followed by Sequential GM-CSF and G-CSF: An Efficient and Predictable PBPC Mobilization Regimen for Autografting: A Single Center Study of Two Hundred and Thirty Patients.

Thomas A. Lane, MD, Lin Liu, PhD, Anita Ihasz, Bridget Medina, Sue Corringham, RN, Peter Holman, MD, Ewa Carrier, MD, Januario Castro, MD, Edward D. Ball, MD, Asad Bashey, MD

Blood (2005) 106 (11): 5281.

https://doi.org/10.1182/blood.V106.11.5281.5281

Published: 2005

NARROW

A Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies.

Prognostic Factors for Long-Term Survival in Metastatic Breast Cancer Patients Treated with High Dose Chemotherapy and Autologous Stem Cell Transplantation

Independent and Interdependent Influence of Number of CD34+ Cells and Use of G-CSF on Outcomes in Autologous PBSCT Patients

Clinical Trial of Therapeutic Blockade of CTLA4 with Ipilimumab in Patients with Relapse of Malignancy Following Allogeneic Hematopoietic Transplantation.

Phase I Study of Ipilimumab (Neutralizing Monoclonal Anti-CTLA4 Antibody) To Treat Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation: Evidence of Tumor Regression without Induction of GVHD.

BEAM Versus CEB Conditioning for Autologous Transplantation in Patients with Non-Hodgkin’s Lymphoma and Hodgkin’s Disease: A Single Center Comparative Study of 219 Patients.

Phase I Study of a Neutralizing Monoclonal Anti-CTLA4 Antibody (MDX-010) in Patients with Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation.

Intermediate Dose Cyclophosphamide Followed by Sequential GM-CSF and G-CSF: An Efficient and Predictable PBPC Mobilization Regimen for Autografting: A Single Center Study of Two Hundred and Thirty Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only